Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study).

Source:http://linkedlifedata.com/resource/pubmed/id/12423717

Am. J. Cardiol. 2002 Nov 15 90 10 1133-4

Download in:

View as

General Info

PMID
12423717